Ligand ups revolving credit line to $125M from $75M

LIGAND PHARMACEUTICALS INC

First amendment to Oct 2023 Credit Agreement executed July 8, 2024, increasing aggregate revolving commitments from $75M to $125M.
Borrowing capacity expanded by $50M; no other material changes detailed in the filing.
Credit facility includes subsidiaries as guarantors; Citibank remains administrative agent, swingline lender and L/C issuer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.